Smart Capital Traders
  • Politics
  • Investing
  • Latest News
  • Stocks

Smart Capital Traders

  • Politics
  • Investing
  • Latest News
  • Stocks
Politics

Lone Republican becomes only lawmaker to vote against crackdown on human organ trafficking

by admin May 8, 2025
May 8, 2025
Lone Republican becomes only lawmaker to vote against crackdown on human organ trafficking

A bill aimed at cracking down on the Chinese Communist Party (CCP) and its practice of forced organ harvesting passed with overwhelming support on Wednesday – though one House lawmaker voted against it.

Rep. Thomas Massie, R-Ky., was the lone Republican to oppose the Stop Forced Organ Harvesting Act, which passed 406-1.

‘It’s just another example of us trying to stick our nose in another country’s business and write their laws,’ Massie told Fox News Digital after the vote. ‘And at the end of the day, they’re gonna do what they’re gonna do, and it’s just sort of a virtue signal over here.’

Massie, a conservative libertarian, often votes against House bills that weigh in on another country’s affairs.

The Kentucky Republican pointed out that he opposed the legislation when it was up for a vote during a previous Congress.

But his pushback is also notable now given his status as an open critic of Speaker Mike Johnson, R-La., and at times, of President Donald Trump. 

The bill was introduced by Rep. Chris Smith, R-N.J., and would authorize the Secretary of State to deny U.S. passports and visitor visas to people involved in organ trafficking circles.

It would also call for sanctions on entities and individuals found to have participated in the gruesome illicit industry.

U.S. lawmakers have accused China of forced organ harvesting of its ideological opponents, including Falun Gong practitioners and Uyghur Muslims. 

This post appeared first on FOX NEWS

previous post
October 7 families demand to know the number of Gaza hostages still alive, after Trump said 3 more have died
next post
Trump announces MAHA advocate Casey Means will be new surgeon general nominee

related articles

FDA phasing out some animal testing in ‘win-win’...

April 11, 2025

DAVID MARCUS: Confusion reigns as Canadians confront Trump’s...

March 10, 2025

Hawley skeptical of Trump pick Oz: ‘I hope...

March 20, 2025

Israel’s strike on Iran took out missile defense...

October 30, 2024

Comer requests Trump DOJ prosecute James Biden for...

January 17, 2025

Democrats join DOGE subcommittee, including member seeking ‘good...

January 22, 2025

Tim Walz slams Elon Musk as a ‘dips—‘...

October 23, 2024

McConnell’s mental acuity targeted by Trump after ex-Senate...

February 16, 2025

Former high-level United Nations officials to launch ‘DOGE-UN’...

December 1, 2024

New resistance battling Trump’s second term through onslaught...

February 12, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Most Popular

    • 1

      Retraction of Forecast Financial Information Plus Announcement on New Metallurgical Testwork Results

      October 15, 2024
    • 2

      Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions

      October 19, 2024
    • 3

      As North Korea, Iran and China support Russia’s war, is a ‘new axis’ emerging?

      October 25, 2024
    • 4

      Lode Gold Launches Exploration Program at One of the Largest Land Packages in New Brunswick

      October 19, 2024
    • 5

      Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

      October 31, 2024

    Categories

    • Investing (1,597)
    • Latest News (1,896)
    • Politics (1,964)
    • Stocks (629)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smartcapitaltraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartcapitaltraders.com | All Rights Reserved